{"id":12087,"date":"2024-08-20T10:30:34","date_gmt":"2024-08-20T17:30:34","guid":{"rendered":"https:\/\/www.qad.com\/blog\/?p=12087"},"modified":"2024-08-20T15:48:51","modified_gmt":"2024-08-20T22:48:51","slug":"csa-and-csv-streamlining-life-sciences-software-validation","status":"publish","type":"post","link":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation","title":{"rendered":"CSA and CSV: Streamlining Life Sciences Software Validation"},"content":{"rendered":"<p>[vc_row][vc_column][vc_single_image image=&#8221;12088&#8243; img_size=&#8221;full&#8221;][vc_column_text]<span style=\"font-weight: 400;\">At the time of this writing, we are only a couple of months away from the two-year anniversary of the FDA\u2019s issuance of the <a target=\"_blank\" href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/computer-software-assurance-production-and-quality-system-software\" rel=\"noopener\">Computer Software Assurance for Production and Quality System Software, Draft Guidance for Industry and Food and Drug and Administrative Staff<\/a>.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">As we approach this milestone, it&#8217;s essential to understand the regulatory landscape that governs software validation in the life sciences industry.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Introduction to FDA&#8217;s Regulatory Requirements on Software and Computer Systems<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">The <\/span><a target=\"_blank\" href=\"https:\/\/www.fda.gov\/about-fda\" rel=\"noopener\"><span style=\"font-weight: 400;\">Food and Drug Administration (FDA)<\/span><\/a><span style=\"font-weight: 400;\"> plays a critical role in ensuring the safety and efficacy of medical devices and pharmaceuticals. One of the essential aspects of regulatory compliance is <\/span><a target=\"_blank\" href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/general-principles-software-validation\" rel=\"noopener\"><span style=\"font-weight: 400;\">software validation<\/span><\/a><span style=\"font-weight: 400;\">, which ensures that computer systems perform their intended functions consistently and reliably. Within this framework, the FDA has established guidelines for Computer System Validation (CSV) and introduced the concept of Computer Software Assurance (CSA) to streamline and enhance the validation process.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">What is Computer System Validation (CSV)?<\/span><\/h2>\n<h3><span style=\"font-weight: 400;\">Definition and Purpose<\/span><\/h3>\n<p><a target=\"_blank\" href=\"https:\/\/www.thefdagroup.com\/blog\/computer-system-validation\" rel=\"noopener\"><span style=\"font-weight: 400;\">Computer System Validation (CSV)<\/span><\/a><span style=\"font-weight: 400;\"> is a comprehensive process that involves documenting and testing software systems to confirm that they meet predetermined specifications and requirements. CSV aims to ensure that software used in regulated environments, such as medical devices and pharmaceutical manufacturing, operates correctly and produces reliable results.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">CSV is an older method of software (system) validation which involves extensive time and documentation (provision of objective evidence) required by the FDA to prove that software meets user needs and does what it is designed to do. CSV Involves testing to provide proof and verification of installation of IQ (Installation Qualification), OQ (Operational Qualification) and PQ (Performance Qualification).\u00a0<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Key Requirements and Guidelines<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Documentation:<\/b><span style=\"font-weight: 400;\"> Thorough documentation of all processes, requirements and testing procedures.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Testing:<\/b><span style=\"font-weight: 400;\"> Rigorous testing to verify that the software performs as intended.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Traceability:<\/b><span style=\"font-weight: 400;\"> Ensuring traceability from requirements to implementation and testing.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Change Control:<\/b><span style=\"font-weight: 400;\"> Managing changes to the software and its environment to maintain validation status.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Benefits of Implementing CSV<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Regulatory Compliance:<\/b><span style=\"font-weight: 400;\"> Ensures adherence to FDA regulations, minimizing the risk of non-compliance.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Quality Assurance:<\/b><span style=\"font-weight: 400;\"> Enhances the reliability and accuracy of software systems.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Risk Mitigation:<\/b><span style=\"font-weight: 400;\"> Identifies and mitigates potential risks associated with software failures<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">How is CSV Related to FDA\u2019s CFR Part 11?\u00a0<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">CSV is a critical component of 21 CFR Part 11 compliance, requiring manufacturers to ensure that computer systems used for electronic records and signatures are reliable, secure, and function as intended.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">It applies to computerized systems that create, modify, maintain, archive, retrieve, or transmit electronic records and signatures in FDA-regulated industries such as the Life Sciences industry.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">What is Computer Software Assurance (CSA)?<\/span><\/h2>\n<h3><span style=\"font-weight: 400;\">Definition and Purpose<\/span><\/h3>\n<p><a target=\"_blank\" href=\"https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/computer-software-assurance-production-and-quality-system-software\" rel=\"noopener\"><span style=\"font-weight: 400;\">Computer Software Assurance (CSA)<\/span><\/a><span style=\"font-weight: 400;\"> is a newer approach introduced by the FDA to streamline the validation process by focusing on critical thinking, risk-based assessment, and automation. CSA aims to make the validation process more efficient and less burdensome while maintaining high standards of quality and compliance.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The FDA introduced this draft guidance to foster life sciences industry use of innovation and help the regulated entities keep pace with changing technology, all while promoting compliance with FDA Computer System Validation (CSV) and <\/span><a target=\"_blank\" href=\"https:\/\/www.ecfr.gov\/current\/title-21\" rel=\"noopener\"><span style=\"font-weight: 400;\">Quality System requirements such as CFR Part 820.70<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">How Industry Feedback and GAMP Guidelines Shape FDA&#8217;s Risk-Based Approach to CSV Compliance<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">The guidance followed feedback from industry participants such as the Medical Device Innovation Consortium, and their concerns about the cost and burden of CSV compliance. Also, from the pharmaceutical industry, the FDA aligned with the <\/span><a target=\"_blank\" href=\"https:\/\/ispe.org\/product-types\/gamp-good-practice-guides\" rel=\"noopener\"><span style=\"font-weight: 400;\">International Society of Pharmaceutical Engineers\u2019 guidelines<\/span><\/a><span style=\"font-weight: 400;\"> entitled \u201cGood Automated Manufacturing Practice\u201d (GAMP 4 and GAMP 5), which also suggest a risk-based approach to compliant software validation.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The ISPE states: \u201cGAMP aims to achieve computerized systems that are fit for intended use and meet current regulatory requirements by building upon existing industry good practice in an efficient and effective manner. \u202fGAMP\u00ae adopts a patient-centric risk-based approach that enables innovation while demonstrating compliance with regulatory requirements.\u201d It is certainly obvious why the FDA can appreciate the ISPE\u2019s GAMP initiative.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">While the CSA\u2019s risk-based approach does not eliminate or replace computer system validation requirements, it should reduce the cost and time burden of compliance on manufacturers, and allow them to more easily leverage technological advancements to produce safe and high quality products for patients efficiently. CSA addresses the unintended consequence of CSV, which is slower adoption of new technologies that would ultimately benefit patients.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">CSA\u2019s Key Differences from CSV<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">CSA does not take a \u201ctest every software and its components equally\u201d approach. CSA puts more emphasis on risk-based analysis to determine appropriate software assurance activities, reducing unnecessary testing. It also allows manufacturers to rely on vendor testing and validation activities, rather than \u201ctesting what has already been tested\u201d by the software vendor. CSA aligns with a broader industry shift away from an older method of software validation. The FDA encourages the use of CSA to reduce the amount of work involved in meeting the required computer system validation requirements.\u00a0<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Risk-Based Approach:<\/b><span style=\"font-weight: 400;\"> Emphasizes assessing and addressing risks based on the software&#8217;s impact on product quality and patient safety.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Critical Thinking:<\/b><span style=\"font-weight: 400;\"> Encourages the use of professional judgment and critical thinking in validation activities.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Automation:<\/b><span style=\"font-weight: 400;\"> Promotes the use of automated testing tools and methods to enhance efficiency.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Benefits of Implementing CSA<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Efficiency:<\/b><span style=\"font-weight: 400;\"> Reduces the time and resources required for validation.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Flexibility: <\/b><span style=\"font-weight: 400;\">Allows for a more tailored approach based on the specific risks and needs of the software.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Innovation:<\/b><span style=\"font-weight: 400;\"> Encourages the adoption of modern technologies and methodologies in the validation process.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">Comparing CSV and CSA<\/span><\/h2>\n<h3><span style=\"font-weight: 400;\">Regulatory Compliance<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Both CSV and CSA are designed to ensure compliance with FDA regulations, but CSA provides a more flexible framework that can adapt to the unique needs of different software systems. CSV focuses on detailed documentation and predefined processes, while CSA allows for a more dynamic approach based on risk assessment and critical thinking.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Risk Management<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">CSV traditionally involves extensive documentation and testing for all aspects of the software, regardless of risk level. In contrast, CSA emphasizes a risk-based approach, focusing resources on areas with the highest potential impact on product quality and patient safety.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Resource Requirements<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">CSV can be resource-intensive due to its comprehensive documentation and testing requirements. CSA aims to reduce the burden by allowing for a more streamlined, risk-based approach, potentially lowering the overall resource requirements.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Implementing CSV and CSA in Practice<\/span><\/h2>\n<h3><span style=\"font-weight: 400;\">Best Practices for Implementing CSV<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Comprehensive Documentation:<\/b><span style=\"font-weight: 400;\"> Maintain detailed records of all validation activities.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Robust Testing:<\/b><span style=\"font-weight: 400;\"> Conduct thorough testing to ensure software reliability.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Change Management:<\/b><span style=\"font-weight: 400;\"> Implement a strict change control process to maintain validation status.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Best Practices for Implementing CSA<\/span><\/h3>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Risk Assessment:<\/b><span style=\"font-weight: 400;\"> Perform a thorough risk assessment to prioritize validation activities.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Critical Thinking:<\/b><span style=\"font-weight: 400;\"> Use professional judgment to determine the most appropriate validation methods.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Automation:<\/b><span style=\"font-weight: 400;\"> Leverage automated tools to enhance efficiency and accuracy.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">What is the difference between \u201ccomputer system validation\u201d and \u201ccomputerized system validation?\u00a0\u00a0<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">In many contexts, the FDA uses these terms somewhat interchangeably. For example, in the guidance on \u201cComputerized Systems Used in Clinical Investigations\u201d, the FDA refers to both &#8220;computerized systems&#8221; and &#8220;computer systems&#8221; without making a clear distinction. In general, \u201ccomputerized system\u201d tends to refer more broadly to technical components and the associated processes and personnel. Nonetheless, the validation process described by the FDA applies similarly whether they are referring to a &#8220;computer system&#8221; or a &#8220;computerized system.&#8221;\u00a0 Regardless of the term used, the FDA\u2019s goal is to ensure that the system\/computerized system consistently produces expected results and meets regulatory requirements.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Planning your approach to software validation<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">CSV remains a reliable and comprehensive approach for ensuring regulatory compliance, while incorporating CSA offers a more flexible and efficient framework to support a modern validation approach. By understanding the differences and benefits of<\/span><span style=\"font-weight: 400;\"> CSA and CSV,<\/span><span style=\"font-weight: 400;\"> organizations can make informed decisions to optimize their software validation processes and ensure compliance with FDA requirements.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The CSA guidance offers valuable recommendations for implementing a risk-based approach to computer system validation. While providing welcome relief, it also emphasizes manufacturers&#8217; freedom to think critically beyond mere regulatory compliance. The guidance encourages evaluation of the biggest areas of risk to patients, and prioritizing heavier validation efforts on processes with the greatest impact on patient safety and product quality, while minimizing time spent on software components and processes unrelated to both. This flexibility allowing for subjectivity has led to lingering questions about CSA.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Join the CSV\/CSA Conversation with Life Science Industry Experts<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Are you using a risk-based approach to computer software validation? What questions, concerns or challenges does your organization have regarding CSA?\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Comment below or <\/span><a target=\"_blank\" href=\"https:\/\/www.qad.com\/industries\/life-sciences#\" rel=\"noopener\"><span style=\"font-weight: 400;\">contact<\/span><\/a><span style=\"font-weight: 400;\"> our experts with any questions, and for an invitation to our Life Sciences Roundtable lunch at <\/span><a target=\"_blank\" href=\"https:\/\/web.cvent.com\/event\/5bda5fa1-3369-479b-a015-0f65df13319b\/summary\" rel=\"noopener\"><span style=\"font-weight: 400;\">QAD Transform Americas 2024<\/span><\/a><span style=\"font-weight: 400;\"> where we will continue the discussion on ways to stay compliant and lighten the administrative burden of computer software validation.<\/span>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column][vc_single_image image=&#8221;12088&#8243; img_size=&#8221;full&#8221;][vc_column_text]At the time of this writing, we are only a couple of months away from the two-year anniversary of the FDA\u2019s issuance of the Computer Software Assurance for Production and Quality System Software, Draft Guidance for Industry and Food and Drug and Administrative Staff. As we approach this milestone, it&#8217;s essential to understand [&hellip;]<\/p>\n","protected":false},"author":175,"featured_media":12088,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[182,199],"tags":[1931,1929,1932,1930,3010,23,27,1351],"class_list":["post-12087","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured","category-manufacturing-trends","tag-computer-software-assurance","tag-computer-software-validation","tag-csa","tag-csv","tag-fda-guidelines","tag-life-sciences","tag-medical-device","tag-software-validation"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CSA and CSV: Streamlining Life Sciences Software Validation | QAD Blog<\/title>\n<meta name=\"description\" content=\"The CSA guidance offers valuable recommendations for implementing a risk-based approach to computer system validation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CSA and CSV: Streamlining Life Sciences Software Validation | QAD Blog\" \/>\n<meta property=\"og:description\" content=\"The CSA guidance offers valuable recommendations for implementing a risk-based approach to computer system validation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation\" \/>\n<meta property=\"og:site_name\" content=\"QAD Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/QADerp\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-20T17:30:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-20T22:48:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.qad.com\/blog\/wp-content\/uploads\/2024\/08\/08_20_2024_A-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Robyn Coward\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@QAD_Community\" \/>\n<meta name=\"twitter:site\" content=\"@QAD_Community\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Robyn Coward\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation\"},\"author\":{\"name\":\"Robyn Coward\",\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/#\\\/schema\\\/person\\\/4e8d7a9ab67f40101795c3ebbbfcafe9\"},\"headline\":\"CSA and CSV: Streamlining Life Sciences Software Validation\",\"datePublished\":\"2024-08-20T17:30:34+00:00\",\"dateModified\":\"2024-08-20T22:48:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation\"},\"wordCount\":1466,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/08_20_2024_A-1.png\",\"keywords\":[\"computer software assurance\",\"computer software validation\",\"CSA\",\"CSV\",\"FDA Guidelines\",\"life sciences\",\"medical device\",\"software validation\"],\"articleSection\":[\"Featured\",\"Manufacturing Trends\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation\",\"url\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation\",\"name\":\"CSA and CSV: Streamlining Life Sciences Software Validation | QAD Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/08_20_2024_A-1.png\",\"datePublished\":\"2024-08-20T17:30:34+00:00\",\"dateModified\":\"2024-08-20T22:48:51+00:00\",\"description\":\"The CSA guidance offers valuable recommendations for implementing a risk-based approach to computer system validation.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation#primaryimage\",\"url\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/08_20_2024_A-1.png\",\"contentUrl\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/08_20_2024_A-1.png\",\"width\":900,\"height\":450,\"caption\":\"CSA, CSV, FDA, medical device\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/2024\\\/08\\\/csa-and-csv-streamlining-life-sciences-software-validation#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CSA and CSV: Streamlining Life Sciences Software Validation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/\",\"name\":\"QAD Blog\",\"description\":\"Next-Generation Manufacturing &amp; Supply Chain Solutions in the Cloud\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/#organization\",\"name\":\"QAD\",\"url\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"QAD\"},\"image\":{\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/QADerp\",\"https:\\\/\\\/x.com\\\/QAD_Community\",\"https:\\\/\\\/instagram.com\\\/qad_erp\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/qad\",\"https:\\\/\\\/www.pinterest.com\\\/QADInc\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/QADIncorporated\\\/\",\"https:\\\/\\\/en.wikipedia.org\\\/wiki\\\/QAD_Inc.\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/#\\\/schema\\\/person\\\/4e8d7a9ab67f40101795c3ebbbfcafe9\",\"name\":\"Robyn Coward\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/robyn-coward_avatar-96x96.jpg\",\"url\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/robyn-coward_avatar-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/robyn-coward_avatar-96x96.jpg\",\"caption\":\"Robyn Coward\"},\"description\":\"Robyn Coward is the Life Sciences Director at QAD. With 21 years of experience in product commercialization, Robyn has spent the last 11 years focused on the global life sciences markets, particularly in the imaging, laboratory diagnostics, and healthcare IT segments. In her role, Robyn monitors and reports on the trends impacting QAD's life sciences customers. She is a member of several industry organizations including the Medical Device Contract Manufacturing Trends Group, Life Sciences Technology and Compliance Group, and the Healthcare Businesswomen's Association. Robyn also participates in various Biocom Institute activities, and enjoys residing in the San Francisco Bay area, one of the world's top hubs for biotechnology, pharmaceutical and medical device development and manufacturing, where she can see exciting and emerging healthcare innovations before they hit the market.\",\"url\":\"https:\\\/\\\/www.qad.com\\\/blog\\\/author\\\/robyn-coward\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CSA and CSV: Streamlining Life Sciences Software Validation | QAD Blog","description":"The CSA guidance offers valuable recommendations for implementing a risk-based approach to computer system validation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation","og_locale":"en_US","og_type":"article","og_title":"CSA and CSV: Streamlining Life Sciences Software Validation | QAD Blog","og_description":"The CSA guidance offers valuable recommendations for implementing a risk-based approach to computer system validation.","og_url":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation","og_site_name":"QAD Blog","article_publisher":"https:\/\/www.facebook.com\/QADerp","article_published_time":"2024-08-20T17:30:34+00:00","article_modified_time":"2024-08-20T22:48:51+00:00","og_image":[{"width":900,"height":450,"url":"https:\/\/www.qad.com\/blog\/wp-content\/uploads\/2024\/08\/08_20_2024_A-1.png","type":"image\/png"}],"author":"Robyn Coward","twitter_card":"summary_large_image","twitter_creator":"@QAD_Community","twitter_site":"@QAD_Community","twitter_misc":{"Written by":"Robyn Coward","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation#article","isPartOf":{"@id":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation"},"author":{"name":"Robyn Coward","@id":"https:\/\/www.qad.com\/blog\/#\/schema\/person\/4e8d7a9ab67f40101795c3ebbbfcafe9"},"headline":"CSA and CSV: Streamlining Life Sciences Software Validation","datePublished":"2024-08-20T17:30:34+00:00","dateModified":"2024-08-20T22:48:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation"},"wordCount":1466,"commentCount":0,"publisher":{"@id":"https:\/\/www.qad.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation#primaryimage"},"thumbnailUrl":"https:\/\/www.qad.com\/blog\/wp-content\/uploads\/2024\/08\/08_20_2024_A-1.png","keywords":["computer software assurance","computer software validation","CSA","CSV","FDA Guidelines","life sciences","medical device","software validation"],"articleSection":["Featured","Manufacturing Trends"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation","url":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation","name":"CSA and CSV: Streamlining Life Sciences Software Validation | QAD Blog","isPartOf":{"@id":"https:\/\/www.qad.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation#primaryimage"},"image":{"@id":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation#primaryimage"},"thumbnailUrl":"https:\/\/www.qad.com\/blog\/wp-content\/uploads\/2024\/08\/08_20_2024_A-1.png","datePublished":"2024-08-20T17:30:34+00:00","dateModified":"2024-08-20T22:48:51+00:00","description":"The CSA guidance offers valuable recommendations for implementing a risk-based approach to computer system validation.","breadcrumb":{"@id":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation#primaryimage","url":"https:\/\/www.qad.com\/blog\/wp-content\/uploads\/2024\/08\/08_20_2024_A-1.png","contentUrl":"https:\/\/www.qad.com\/blog\/wp-content\/uploads\/2024\/08\/08_20_2024_A-1.png","width":900,"height":450,"caption":"CSA, CSV, FDA, medical device"},{"@type":"BreadcrumbList","@id":"https:\/\/www.qad.com\/blog\/2024\/08\/csa-and-csv-streamlining-life-sciences-software-validation#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.qad.com\/blog\/"},{"@type":"ListItem","position":2,"name":"CSA and CSV: Streamlining Life Sciences Software Validation"}]},{"@type":"WebSite","@id":"https:\/\/www.qad.com\/blog\/#website","url":"https:\/\/www.qad.com\/blog\/","name":"QAD Blog","description":"Next-Generation Manufacturing &amp; Supply Chain Solutions in the Cloud","publisher":{"@id":"https:\/\/www.qad.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.qad.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.qad.com\/blog\/#organization","name":"QAD","url":"https:\/\/www.qad.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.qad.com\/blog\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"QAD"},"image":{"@id":"https:\/\/www.qad.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/QADerp","https:\/\/x.com\/QAD_Community","https:\/\/instagram.com\/qad_erp\/","https:\/\/www.linkedin.com\/company\/qad","https:\/\/www.pinterest.com\/QADInc\/","https:\/\/www.youtube.com\/user\/QADIncorporated\/","https:\/\/en.wikipedia.org\/wiki\/QAD_Inc."]},{"@type":"Person","@id":"https:\/\/www.qad.com\/blog\/#\/schema\/person\/4e8d7a9ab67f40101795c3ebbbfcafe9","name":"Robyn Coward","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.qad.com\/blog\/wp-content\/uploads\/2024\/04\/robyn-coward_avatar-96x96.jpg","url":"https:\/\/www.qad.com\/blog\/wp-content\/uploads\/2024\/04\/robyn-coward_avatar-96x96.jpg","contentUrl":"https:\/\/www.qad.com\/blog\/wp-content\/uploads\/2024\/04\/robyn-coward_avatar-96x96.jpg","caption":"Robyn Coward"},"description":"Robyn Coward is the Life Sciences Director at QAD. With 21 years of experience in product commercialization, Robyn has spent the last 11 years focused on the global life sciences markets, particularly in the imaging, laboratory diagnostics, and healthcare IT segments. In her role, Robyn monitors and reports on the trends impacting QAD's life sciences customers. She is a member of several industry organizations including the Medical Device Contract Manufacturing Trends Group, Life Sciences Technology and Compliance Group, and the Healthcare Businesswomen's Association. Robyn also participates in various Biocom Institute activities, and enjoys residing in the San Francisco Bay area, one of the world's top hubs for biotechnology, pharmaceutical and medical device development and manufacturing, where she can see exciting and emerging healthcare innovations before they hit the market.","url":"https:\/\/www.qad.com\/blog\/author\/robyn-coward"}]}},"_links":{"self":[{"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/posts\/12087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/users\/175"}],"replies":[{"embeddable":true,"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/comments?post=12087"}],"version-history":[{"count":6,"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/posts\/12087\/revisions"}],"predecessor-version":[{"id":12096,"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/posts\/12087\/revisions\/12096"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/media\/12088"}],"wp:attachment":[{"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/media?parent=12087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/categories?post=12087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.qad.com\/blog\/wp-json\/wp\/v2\/tags?post=12087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}